- Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Biohaven Pharmaceutical Holding
Company Profile
Quarter (USD) | Jun 22 | Mar 22 | Dec 21 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 236.56 mm | 236.56 mm | 236.56 mm | 236.56 mm | 236.56 mm | 236.56 mm |
Cash burn (monthly) | (no burn) | 5.97 mm | 147.27 mm | 75.78 mm | (no burn) | 35.01 mm |
Cash used (since last report) | n/a | 191.41 mm | 4.72 bn | 2.43 bn | n/a | 1.12 bn |
Cash remaining | n/a | 45.15 mm | -4.49 bn | -2.19 bn | n/a | -886.74 mm |
Runway (months of cash) | n/a | 7.6 | -30.5 | -29.0 | n/a | -25.3 |
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|